LDL Control Causal Tree

Similar documents
Follow-up on Blood Pressure Protocols. September 20, 2017

Appendix 5. PCSP PCMH 2014 Crosswalk

Promoting Interoperability Measures

APPENDIX 2 NCQA PCMH 2011 AND CMS STAGE 1 MEANINGFUL USE REQUIREMENTS

Transitions of Care: From Hospital to Home

Asthma Disease Management Program

PCSP 2016 PCMH 2014 Crosswalk

Use of Information Technology in Physician Practices

CLINICAL PRACTICE EVALUATION II: CLINICAL SYSTEMS REVIEW

Total Cost of Care in Action

Safe Transitions Best Practice Measures for

Practice Transformation: Patient Centered Medical Home Overview

PCMH 2014 Recognition Checklist

Promoting Interoperability Performance Category Fact Sheet

The Heart and Vascular Disease Management Program

Medication Management: Is It in Your Toolbox?

CHRONIC CARE MANAGEMENT IMPLEMENTATION GUIDE

Advancing Care Information Performance Category Fact Sheet

Keenan Pharmacy Care Management (KPCM)

RN Behavioral Health Care Manager in Behavioral Health Settings

Annual Reporting Requirements for PCMH Recognition Overview & Table Reporting Period: 4/3/ /31/2018

Comprehensive Medication Management (CMM) for Hypertension Patients: Driving Value and Sustainability

Medicare: This subset aligns with the requirements defined by CMS and is for the review of Medicare and Medicare Advantage beneficiaries

Early Recognition of Sepsis in Long-Term Care

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES

Advancing Care Information Measures

Patient Centered Medical Home 2011

Patient and Family Caregiver Interview Tool

READMISSION ROOT CAUSE ANALYSIS REPORT

Home Health Quality Improvement Campaign

QAA/QAPI Meeting Agenda Guide

Healthcare Effectiveness Data and Information Set (HEDIS)

PBSI-EHR Off the Charts Meaningful Use in 2016 The Patient Engagement Stage

Practice Tools for Safe Drug Therapy

Health Home Flow Hypothetical Patient Scenario

Post-Test/ Evaluation

CPOM TRAINING. Page 1

Strategies to Improve Medication Adherence It Can Be SIMPLE

Improving patient safety and infection. Patient Safety Forum Dr J Coleman 1 ELECTRONIC PRESCRIBING AND CLINICAL DECISION SUPPORT (CDS)

Registry Essentials for BH Care Managers

COLLABORATIVE PRACTICE SUCCESSES IN PRIMARY CARE

Medication Related Changes Phase 1&2

Quality and Improvement Activities Aaron Hubbard

Using Quality Reporting and Health Information Technology to Improve Patient Care. Thursday, April 21, 2016 David Smith Acumentra Health

Feature Medication Adherence

Risk Adjusted Diagnosis Coding:

Care Management Policies

Medication Management of Chronic Diseases in a Medical Home Model: CMS Medicaid Transformation Project

MyHealth Advantage Program Overview

Scotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists

Improving Primary Care Medication Patient Safety: System-level Medication Adherence Issues

EHR Incentives. Profit by using LOGO a certified EHR. EHR vs. EMR. PQRI Incentives. Incentives available

April Data Jam: Tracking Progress and Facilitating Improvement with your Data Dashboard

TRANSITIONS of CARE. Francis A. Komara, D.O. Michigan State University College of Osteopathic Medicine

Measures Reporting for Eligible Hospitals

Meaningful Use Modified Stage 2 Roadmap Eligible Hospitals

Appendix 4 CMS Stage 1 Meaningful Use Requirements Summary Tables 4-1 APPENDIX 4 CMS STAGE 1 MEANINGFUL USE REQUIREMENTS SUMMARY

Annual Reporting Requirements for PCMH Recognition Overview & Table Reporting Period: 4/3/2017 3/31/2018

Oncology Pharmacy Services

Tips for PCMH Application Submission

Procedure Code Job Aid

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements

Meaningful Use: Review of Changes to Objectives and Measures in Final Rule

Patient-Centered Specialty Practice (PCSP) Recognition Program

MODULE 8 1. Module 8 Learning Objectives. Adolescent HIV Care and Treatment. Module 8: Module 8 Learning Objectives (Continued) Session 8.

Annual Wellness Visit (AWV) Delivery Business Case

Patient-Centered Connected Care 2015 Recognition Program Overview. All materials 2016, National Committee for Quality Assurance

TRANSITIONS OF CARE: INCREASING PATIENT ENGAGEMENT AND COMMUNICATION ACROSS HEALTH CARE SETTINGS

UPDATE ON MEANINGFUL USE. HITECH Stimulus Act of 2009: CSC Point of View

Medication Adherence: Strategies for Improving Outcomes

RULE RESPONSIBILITIES OF A PHYSICIAN WHO ENGAGES IN DRUG THERAPY MANAGEMENT WITH A COLORADO LICENSED PHARMACIST

Page 2 of 29 Questions? Call

HouseCalls Objectives

Blending Behavioral Health and Primary Care. Applying the Model. Brittany Tenbarge, Ph.D. Behavioral Health Consultant Licensed Clinical Psychologist

Health Management Information Systems: Computerized Provider Order Entry

Topic 3B: Documentation Prep for NCQA Recognition Focus on Standards 3, 4, and 1F

CHRONIC CARE MANAGEMENT TOOL KIT What Practices Need to Do to Implement and Bill CCM Codes

PCMH 1A Patient Centered Access

eprescribing Information to Improve Medication Adherence

MEANINGFUL USE STAGE 2

FACTS AND FIGURES 120, ,000 - The estimated number of people with FH in the UK

CONNECTED SM. Blue Care Connection SIMPLY AN ACTIVE APPROACH TO INTEGRATED HEALTH MANAGEMENT

ASCO s Quality Training Program

Successful disease management requires technology that can measure progress, show gaps

Medication Therapy Management

WEBINAR: Check. Change. Control. Cholesterol April 4, 2018

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 1

Performance Measurement of a Pharmacist-Directed Anticoagulation Management Service

Corporate Reimbursement Policy Telehealth

Provider Manual. Utilization Management Care Management

A Pharmacist Network for Integrated Medication Management in the Medical Home

YOUR HEALTH INFORMATION EXCHANGE

EHR Innovations for Improving Hypertension Challenge Winners and Phase 2

4/28/2017. Medication Management for Improved Compliance & Home Care Satisfaction PREPARED FOR NEHCC Presenter. Overview

Preventing Heart Failure Readmissions by Using a Risk Stratification Tool

Generations Advantage Focus DC (HMO SNP) Diabetes Care Special Needs Plan GENERAL MODEL OF CARE (MOC) TRAINING

CMS RULES FOR PARTICIPATION/LTC REGULATIONS: WHAT YOU NEED TO KNOW

General Office and Patient Compliance Policies

PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK

Primary Care Specialist Physician Compact

Transcription:

LDL Control Causal Tree This material was prepared by HealthInsight, the Medicare Quality Innovation Network Quality Improvement Organization for Nevada, New Mexico, Oregon Utah, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health Human Services. The contents presented do not necessarily reflect CMS policy. 11SOW B1 16 03

Heart Disease (LDL Cholesterol) A Patient aware of LDL B Patient unaware LDL elevated A1 Patient untreated A2 Patient treated A2.1 Patient at goal A2.2 Patient not at goal A2.2.1 Inaccurate LDL measurement A2.2.2 Low patient adherence (therapy) A2.2.2 Resistant LDL (tough disease genetic) A2.2.3 Side effects cannot tolerate therapy A2.2.4 Suboptimal prescription regimen A2.2.5 Therapeutic inertia

B Patient Unaware LDL Elevated B1 No contact with health care system ( probability) B2 Office visit but LDL not taken B3 Heart disease not diagnosed ( probability) B1.1 No insurance or low income B1.2 Low patient priority (no symptoms) B1.3 No regular patient contact with system (e.g., regular physicals)

B2 Office Visit but LDL Not Taken B2.1 Nurse/MA/provider plans to take but B2.2 No system reminder B2.3 Patient know or remind B2.4Nurse/MA/ provider know to do LDL test B2.5 Patient not fasting B2.1.1 Equipment Failure B2.1.2 Nurse/MA/provider busy B2.1.1.1 Equipment not working B2.1.1.1.1 Equipment not checked regularly B2.1.3 Nurse/MA/provider distracted B2.1.1.2 Equipment not available B2.1.1.2.1 Not enough equipment B2.1.4 Nurse/MA forgets B2.4.1.1 Patient prompt B2.4.1 No order from provider B2.4.2 Incomplete training B2.4.1.2 System prompt (human or electronic)

B3 Patient not Diagnosed ( Probability) B3.1 Documentation of diagnosis not available during encounter B3.2 High LDL documented, but not evident to provider B3.1.1 Chart/lab unavailable (lost, misplaced, EHR down, or no lab interface) B3.1.2 LDL not taken (see branch B2) B3.2.1 Provider does not review or flag B3.2.2 Patient prompt B3.2.3 System prompt (human or electronic) B3.2.1.1 Provider intends to review LDL results but (forgets) B3.2.1.2 Provider s process does not include LDL review B3.2.1.3 Result tagged as high cannot calculate LDL B3.2.1.4 Provider trust result B3.2.3.1 High reading not flagged by nurse/ma B3.2.3.2 EHR does not flag

A1 Patient Untreated, Diagnosed with Heart Disease A1.1.1 Younger, male A1.1 Inadequate access A1.1.2 Hispanic A1.2 Low priority condition for patient (no symptoms, no urgency, patient does not want to be seen) A1.1.3 Low income A1.1.4 No insurance A1.3 Provider distracted by separate acute episode A1.3.1 Patient prompt A1.3.2 System does not prompt (human or electronic) A1.4 New baseline needed old LDL lab not trusted

A2.2.2 Low Patient Adherence (Therapy) A2.2.2.1 Patient does not comply A2.2.2.2 Provider initiating failure A2.2.2.3 Provider detect correct (see therapeutic inertia branch) A2.2.2.1.1 Prescription A2.2.2.1.2 Lifestyle (diet/ physical activity) A2.2.2.1.3 Alcoholism A2.2.2.1.4 Co morbidities comm attention A2.2.2.1.5 Mental health A2.2.2.1.5.1 Mental health meds override effects of LDL meds A2.2.2.1.5.2 Dementia /or depression A2.2.2.1.5.3 Only sees mental health doctor

A2.2.2.1.1 Prescription A2.2.2.1.1.1 No visible symptoms with meds A2.2.2.1.1.2 Dislikes side effects pursue A2.2.2.1.1.3 Cost of prescription high no insurance or limited formulary A2.2.2.1.1.5 No provider feedback/ reinforcement A2.2.2.1.1.6 Does not know to refill prescription A2.2.2.1.1.7 Lack of education as to why prescription needed A2.2.2.1.1.4 System does not detect no fills, refills, feedback A2.2.2.1.1.4.1 Insurance A2.2.2.1.1.4.2 Pharmacy A2.2.2.1.1.4.3 EHR

A2.2.2.1.2 Lifestyle (Diet/Physical Activity) A2.2.2.1.2.1 Too difficult to change lifestyle A2.2.2.1.2.2 Say they have changed but have not A2.2.2.1.2.3 Changed but not at goal failure to see why medication needed A2.2.2.1.2.4 Does not underst what elevated LDL is /or importance A2.2.2.1.2.1.1 Family. friends not supportive A2.2.2.1.2.1.2 Fat reduced foods not available A2.2.2.1.2.1.3 Time constraints A2.2.2.1.2.1.4 No provider feedback (failure to reinforce) A2.2.2.1.2.1.5 Cultural issues A2.2.2.1.2.4.1 Language barriers A2.2.2.1.2.4.2 Insufficient or no patient education A2.2.2.1.2.4.3 Insurance cover education

A2.2.5 Therapeutic Inertia A2.2.5.1 Provider does not detect correct A2.2.5.2 Patient initiate dialogue or prompt A2.2.5.3 System (electronic or human) prompt A2.2.5.1.1 Competing dems/ limited time A2.2.5.1.2 Ineffective feedback response when LDL goal not met A2.2.5.1.3 Unclear role communication patient sees more than one provider A2.2.5.1.4 Soft clinical reasoning ( probability) A2.2.5.1.2.1 Failure to modify treatment plan A2.2.5.1.2.2 Guidelines not followed A2.2.5.1.2.3 No patient follow up A2.2.5.1.1.1 No team care (failure to delegate) A2.2.5.1.1.2 More urgent concerns ( probability) A2.2.5.1.1.3 Failure to detect non adherence A2.2.5.1.2.2.1 Guidelines changed, practice did not A2.2.5.1.2.2.2 Not familiar with guidelines A2.2.5.1.2.2.3 Feels that risks of prescription outweigh benefits

A2.2.5.1.4 Soft Clinical Reasoning A2.2.5.1.4.1 Satisfied with patient s current results/progress A2.2.5.1.4.2 Does not believe LDL is important A2.2.5.1.4.3 Prefers behavioral to medicinal Intervention A2.2.5.1.4.4 Does not trust lab result A2.2.5.1.4.5 Fail to set goal, dose appropriately

A2.2.5.1.2.1 Failure to Modify Treatment Plan A2.2.5.1.2.1.1 Treatment plan not activated A2.2.5.1.2.1.2 No plan for treatment A2.2.5.1.2.1.3 Treatment plan not adequate A2.2.5.1.2.1.4 Implemented 2.2.5.1.2.1.1.1 Provider has plan but does not activate yet A2.2.5.1.2.1.1.2 Provider has activated a partial plan (see not adequate ) A2.2.5.1.2.1.1.1.1 Wait see A2.2.5.1.2.1.1.1.2 Wants to address other issues first A2.2.5.1.2.1.2.1 Patient concerns A2.2.5.1.2.1.2.2 Other A2.2.5.1.2.1.3.1 Lifestyle (education) A2.2.5.1.2.1.3.2 First round medications (education/monitoring) A2.2.5.1.2.1.3.3 Second round medications (education/monitoring) A2.2.5.1.2.1.3.4 Inadequate clinical systems to support plan

A2.2.5.1.2.3 No Patient Follow up A2.2.5.1.2.3.1 Patient overdue A2.2.5.1.2.3.2 Provider have a practice of following up (no system, not team, not EHR or sees as patient responsibility) A2.2.5.1.2.3.3 No system follow up (feedback loop) A2.2.5.1.2.3.1.1 Patient is told to follow up with provider A2.2.5.1.2.3.1.1.1 Provider has a practice of following up but A2.2.5.1.2.3.1.1.1.1 Busy A2.2.5.1.2.3.1.1.1.2 Forgets A2.2.5.1.2.3.1.1.1.3 Chart unavailable (lost/misplaced/ EHR down) A2.2.5.1.2.3.1.1.1.4 Chart flags/ prompts/registries fail A2.2.5.1.2.3.1.1.1 Patient intends to schedule appointment but A2.2.5.1.2.3.1.1.2 Patient schedules appointment but LDL not addressed A2.2.5.1.2.3.1.1.3 Patient intend to schedule (See A2.2.2 branch) A2.2.5.1.2.3.1.1.1.1 Busy A2.2.5.1.2.3.1.1.1.2 Forgets A2.2.5.1.2.3.1.1.1.3 Transportation is a challenge